|
Indivior PLC - Richmond, Virginia-based pharmaceutical maker focused on treating opioid addiction - Indivior shares are cancelled from trading in London on Friday as the company focuses on its primary listing on Nasdaq in New York. It had announced its plan to delist from London at the start of June, saying that 80% of its revenue and 75% of its share trading volume is in the US. Formerly based in Slough, England, Indivior was part of heath and hygiene consumer products firm Reckitt Benckiser Group PLC before being spun out in late 2014. Current stock price in New York: $16.81 for £1.54 billion market capitalisation 12-month change: up 28% Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
